|
Welcome to the Medicines for Children Research Network (MCRN) The NIHR Medicines for Children Research Network (MCRN) has been created to improve the co-ordination, speed and quality of randomised controlled trials and other well designed studies of medicines for children and adolescents, including those for prevention, diagnosis and treatment. The Network has extensive knowledge and experience of paediatric research, and supports non-commercial, pharmaceutical/biotech-sponsored and investigator-led partnership studies in over 100 NHS sites in England that serve approximately 6 million children. The MCRN supports studies through its infrastructure, which includes the MCRN Coordinating Centre, Local Research Networks (LRNs), Clinical Studies Groups (CSGs), Clinical Trial Units (CTUs) and a Neonatal Network. The MCRN Coordinating Centre is led by a consortium comprising the University of Liverpool, Royal Liverpool Children’s Hospital, Imperial College London, National Perinatal Epidemiology Unit (NPEU; University of Oxford), Liverpool Women’s Hospital and the National Children’s Bureau. The NIHR MCRN is funded by the Department of Health and works in partnership with the NIHR Clinical Research Network (NIHR CRN) to improve the UK’s clinical research environment and maximise the development of safe and effective medicines and formulations for children.
** VIEW A SHORT VIDEO CLIP ABOUT THE MCRN HERE **
Interested in MCRN Job/CSG Vacancies? Please go to the Jobs section for more information. To access the MCRN Brochure, please click here To access the NIHR CRN Portfolio Database (studies adopted to the MCRN portfolio), please click here The NIHR Medicines for Children Research Network is part of the National Institute for Health Research and the NIHR Clinical Research Network      logo.gif "Image") logo.gif "Image")
|
|
